Market Cap
$180.99 M
+$2.56 M+1.43%
Thu, 28 Nov 2024 00:56:32 GMT
Summary:
Adaptimmune Therapeutics market capitalization is currently $180.99 million, with a rise of +$2.56 million (+1.43%) during the most recent trading day. Over the past year, it has increased by +$78.65 million (+76.85%). ADAP market cap is now -89.66% below its all-time high of $1.75 billion.ADAP Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +1.4% | +1.4% | +0.0% | - |
| 1 m1 month | -6.0% | -6.1% | - | - |
| 3 m3 months | -42.0% | -42.0% | - | - |
| 6 m6 months | -31.2% | -31.3% | - | - |
| ytdytd | +0.8% | -10.5% | - | - |
| 1 y1 year | +76.8% | +57.0% | +12.7% | - |
| 5 y5 years | +80.2% | -25.9% | +143.3% | - |
ADAP Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $213 M | -15.1% | $154 M | +17.9% |
| 3 m | 3 months | $330 M | -45.1% | $154 M | +17.9% |
| 6 m | 6 months | $363 M | -50.2% | $154 M | +17.9% |
| 1 y | 1 year | $454 M | -60.1% | $101 M | +79.2% |
| 3 y | 3 years | $648 M | -72.1% | $95 M | +89.7% |
| 5 y | 5 years | $1.75 B | -89.7% | $95 M | +89.7% |
| alltime | all time | $1.75 B | -89.7% | $76 M | +137.4% |
Adaptimmune Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2024 | $180.99 M(+0.8%) |
| 2023 | $179.46 M(-24.2%) |
| 2022 | $236.66 M(-59.6%) |
| 2021 | $585.97 M(-29.8%) |
| 2020 | $834.33 M(+561.1%) |
| Date | Value |
|---|---|
| 2019 | $126.20 M(-79.0%) |
| 2018 | $601.31 M(-3.9%) |
| 2017 | $625.83 M(+118.3%) |
| 2016 | $286.72 M(-66.4%) |
| 2015 | $853.67 M |
FAQ
- What is Adaptimmune Therapeutics market capitalization?
- What is the all time high market cap for Adaptimmune Therapeutics?
- What is ADAP market capitalization year-to-date change?
- What is Adaptimmune Therapeutics market cap year-on-year change?
What is Adaptimmune Therapeutics market capitalization?
The current market cap of ADAP is $180.99 M
What is the all time high market cap for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high market capitalization is $1.75 B
What is ADAP market capitalization year-to-date change?
Adaptimmune Therapeutics market capitalization has changed by +$1.52 M (+0.85%) since the beginning of the year
What is Adaptimmune Therapeutics market cap year-on-year change?
Over the past year, ADAP market capitalization has changed by +$78.65 M (+76.85%)